Hemfosa acquires community service properties in Sweden for a value of MSEK 135
Hemfosa has signed an agreement to acquire a portfolio of community service properties with an underlying property value of MSEK 135. In total, the portfolio comprises 16 properties in Sweden. The acquisition entails an expansion of Hemfosa’s portfolio in the area of healthcare and personal care properties.
Hemfosa is acquiring a property portfolio comprising 16 properties in ten locations across Sweden, including Gävle, Hässleholm, Skövde, Västerås and Gotland. The seller is Humana AB. The properties are fully leased to the care company Humana AB, which operates homes for people with special needs and residential care facilities at the properties. The properties comprise a combined total of approximately 7,000 sqm of leasable area, with an average lease of 13.6 years. The total rental value is about MSEK 9.1.
Possession of the properties has been taken, June 30, 2017.
“This acquisition has further strengthened Hemfosa’s position in care services and healthcare properties in Sweden. We look forward to continuing to develop our partnership with Humana – a well-established and growing societal player in the Nordic region,” says Stina Lind Hök, Head of Transactions at Hemfosa.
For further information, please contact:
Stina Lindh Hök, Head of Transactions, email@example.com, mobile +46 70 577 18 85, office +46 8 448 04 80
About Hemfosa Fastigheter
Hemfosa is a Swedish property company focusing on community service properties in the Nordic region with its largest tenants being the Swedish state and municipalities. This provides stable cash flows and a healthy yield. In order to create value, Hemfosa also aims to actively participate in the transaction market. As per March 31, 2017, Hemfosa owned properties with a total property value of approximately SEK 35.8 billion, excluding the company’s share of the property value in joint ventures. The company’s ordinary share has been listed since March 2014, and the preference share since December 2014, both on Nasdaq Stockholm. Read more at www.hemfosa.se.